propidium has been researched along with fingolimod hydrochloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azedi, F; Ebrahimi-Barough, S; Hoveizi, E; Joghataei, MT; Keyhanvar, P; Tavakol, B; Tavakol, S | 1 |
1 other study(ies) available for propidium and fingolimod hydrochloride
| Article | Year |
|---|---|
Small molecule of sphingosine as a rescue of dopaminergic cells: A cell therapy approach in neurodegenerative diseases therapeutics.
Topics: bcl-2-Associated X Protein; Calcium Channels, L-Type; Cell Line; Cell Survival; Dopaminergic Neurons; Fingolimod Hydrochloride; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Humans; Immunosuppressive Agents; L-Lactate Dehydrogenase; Nitric Oxide; Propidium; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, GABA-A; Sphingosine; Tyrosine 3-Monooxygenase | 2019 |